2008 Sabin Young Investigator Award
Katherine L. O'Brien, M.D., M.P.H.
Katherine L. O'Brien is a pediatric infectious disease physician and epidemiologist who earned her M.D. at McGill University and her M.P.H. at Johns Hopkins University. Following residency and fellowship at Johns Hopkins, she joined the Bacterial Respiratory Diseases Branch at the Centers for Disease Control and Prevention as a
n Epidemiologic Intelligence Officer. Dr. O'Brien returned to Johns Hopkins in 1998 to join the Center for American Indian Health, where she leads the Center's Infectious Disease Group, conducting clinical trials of vaccines for diseases of importance to American Indian tribes. Dr. O'Brien is also the Deputy Director of Research for GAVI's PneumoADIP, which aims to accelerate the development and introduction of pneumococcal vaccines for children globally. Her work domestically and internationally has focused on epidemiologic and vaccine studies of pneumococcal disease; rotavirus; Haemophilius influenzae; respiratory syncytial virus; influenza; and Helicobacter pylori. Dr. O'Brien is married and has two children, Emma and Jack, who are 10 and 9 years old.
2006 Humanitarian Award
Garo H. Armen, Ph.D.
Chairman and CEO, Antigenics, Inc.
Garo H. Armen is chairman and chief executive officer of Antigenics Inc., the biotechnology company he cofounded with Pramod Srivastava in 1994. From mid-2002 through 2004, he was also chairman of the board of directors for the biopharmaceutical company Elan Corporation, where he successfully engineered the restructuring of the company. Dr. Armen is also the founder and chairman of the Children of Armenia Fund (COAF), a charitable organization dedicated to the positive development of the children and youth of Armenia.
Prior to Antigenics, Dr. Armen established Armen Partners, a money management firm specializing in biotechnology and pharmaceutical companies, and was the architect of the widely publicized creation of the Immunex Lederle oncology business in 1993. Earlier, he was a senior vice president of research at Dean Witter Reynolds, having begun his career on Wall Street as an analyst and investment banker at EF Hutton.
Before entering finance, Dr. Armen was a research fellow at Brookhaven National Laboratories in Long Island, NY. He received a Ph.D. in physical chemistry from the Graduate Center, City University of New York.
2006 Award for Scientific Excellence
Prof. Ruth Arnon, Ph.D.
Immunologist, Weizmann Institute of Science
Formerly Vice-President of the Weizmann Institute of Science (1988-1997), Prof. Ruth Arnon is a noted immunologist. Prof. Arnon has made significant contributions to the fields of vaccine development, cancer research and to the study of parasitic diseases. Along with Prof. Michael Sela, she developed Copaxone,® a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration, and is presently marketed in the USA, Canada, the EU, Israel, Australia and many other countries worldwide.
Prof. Arnon joined the staff of the Weizmann Institute in 1960. Prior to her appointment as Vice-President, she served as Head of the Department of Chemical Immunology, and as Dean of the Faculty of Biology. From 1985 to 1994, she was the Director of the Institute's MacArthur Center for Molecular Biology of Tropical Diseases. Prof. Arnon is a member of the Israel Academy of Sciences, and serves as its Vice-President since 2004. On the world scene, she is an elected member of the European Molecular Biology Organization (EMBO). She has served as President of the European Federation of Immunological Societies (EFIS), as Secretary-General of the International Union of Immunological Societies (IUIS), and as a member of the European Union's Research Advisory Board (EURAB). She currently is the President of the Association of Academies of Sciences in Asia (AASA). Along the years she served as a member of the Board of Trustees of many organizations including the Sabin Vaccine Institute and the International Vaccine Institute in Seoul (IVI). Prof. Arnon is also the Scientific Advisor to the President of the State of Israel. Her awards and honors include the Robert Koch Prize in Medical Sciences, Spain's Jimenez Diaz Memorial Award, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology, and the Israel Prize. At the Weizmann Institute, Prof. Arnon is the incumbent of the Paul Ehrlich Professorial Chair in Immunochemistry.
2006 Health Media Award
G. Timothy Johnson, M.D.
Medical Editor, ABC News
Dr. G. Timothy Johnson is one of the nation's leading medical communicators of health care information. As Medical Editor for ABC News, Johnson provides on-air medical analysis for "World News Tonight", "Nightline" and "20/20." He has provided commentary on medical problems and answers for viewers of ABC News' "Good Morning America" since the program's debut in 1975.
Johnson's programs and feature reports have won several awards, including an Emmy Award from the National Academy of Television Arts and Sciences as well as two Emmy Awards from the Boston/New England Chapter of the same organization. In 1999, he earned a Gabriel Award in the best news story category for the two-part piece, "Alzheimer's: A Faded Memory." Johnson was selected as the recipient of the 1998 Bradford Washburn Award presented by the Museum of Science, Boston -- an honor also bestowed upon Jacques Cousteau, Walter Cronkite, Dr. Jane Goodall and Alan Alda, among others. In 1988, he received the Lewis Thomas Award for Communications from the American College of Physicians, and in 1987 and 1989, he won the Howard W. Blakeslee Award given by the American Heart Association.
Johnson is the founding editor of the Harvard Medical School Health Letter and co-editor of the "Harvard Medical School Health Letter Book." He is also co-editor of the book "Your Good Health", co-author of "Let's Talk", and author of "Dr. Timothy Johnson's OnCall Guide to Men's Heath" and "Finding God in the Questions: A Personal Journey."
Originally headed for the ministry, he graduated in from North Park Seminary in 1963, then decided two years later to enter medicine. A Phi Beta Kappa graduate of Augustana College, he graduated summa cum laude from Albany Medical College and holds a masters degree in public health from Harvard University. He is on the faculty at Harvard Medical School and is on the staff of Massachusetts General Hospital. Johnson is married, and is the father of two children and one grandchild.
2005 Humanitarian Award
Wayne T. Hockmeyer, Ph.D.
Chairman and Founder MedImmune, Inc. and president, MedImmune Ventures, Inc.
Dr. Wayne T. Hockmeyer founded MedImmune, Inc. in April 1988, serving initially as president and chief executive officer. He was elected to serve on the MedImmune Board of Directors in May 1988 and became chairman of the board in May 1993. Dr. Hockmeyer relinquished his post as chief executive officer in October 2000 and now serves as the chairman of the board of directors and president of MedImmune Ventures, Inc. Dr. Hockmeyer earned his bachelor’s degree from Purdue University and earned his Ph.D. from the University of Florida in 1972. Prior to founding MedImmune, Dr. Hockmeyer served as a commissioned officer in the United States Army from 1966 to 1986. From 1980 to 1986 he was chairman of the Department of Immunology at the Walter Reed Army Institute of Research. In 1986, Dr. Hockmeyer joined Praxis Biologics as vice president of research and development and was there until founding MedImmune, Inc. in 1988. Active in other leadership roles, Dr. Hockmeyer is a member of the Maryland Economic Development Commission and is a member of the Governor’s Workforce Investment Board (GWIB). He is a member of the boards of directors of Advancis Pharmaceutical Corporation, Idenix Pharmaceuticals, GenVec, Inc., and TolerRx. Dr. Hockmeyer is also a member of the Board of Directors of the Technology Council of Maryland, a member of the Board of Visitors of the University of Maryland Biotechnology Institute and the University of Maryland Baltimore County and the Board of Trustees of the University of Maryland College Park Foundation. He is also a member of the Board of Governors of The Chesapeake Bay Maritime Museum. Prior to his business career, Dr. Hockmeyer was recognized internationally for his research on malaria vaccines. He has authored more than 70 papers and articles in the immunology and vaccine development fields. He is a Paul A. Siple Medal winner. His achievements in business were recognized in 1993 when he was selected as the "Ernst & Young Greater Washington Entrepreneur of the Year." Dr. Hockmeyer was recognized in 1998 by the University of Florida as a Distinguished Alumnus. In 2002, he was awarded a Doctor of Science honoris causa from Purdue University. He was also a 2003 inductee to the Maryland Business Hall of Fame and was named Washington Business Leader of the Year 2003 by The Washingtonian Magazine, July 2003. He is the 2004 CEO of the Year of The George Washington University School of Business.
James F. Young, Ph.D.
President, Research & Development, MedImmune, Inc.
Dr. Young has over more than 30 years of experience in the fields of molecular genetics, microbiology, immunology, and pharmaceutical development. In December 2000, Dr. Young was promoted to the position of president, research and development, at MedImmune, Inc., with responsibility for overseeing the research, preclinical, and clinical development of all MedImmune products. Recently, he was also given responsibility for regulatory affairs. Dr. Young joined MedImmune in 1989 as vice president, research and development. In 1995, he was promoted to senior vice president and in 1999 he was promoted to executive vice president, research and development. Throughout this period, he supervised the preclinical development of the company’s flagship product, Synagis®, which is the first monoclonal antibody approved for an infectious disease. Prior to MedImmune, from 1983 to 1989, Dr. Young was instrumental in building the department of molecular genetics at Smith Kline & French Laboratories culminating in the position of director, department of molecular genetics. From 1978 to 1983, he was on the faculty of the department of microbiology at Mount Sinai School of Medicine in New York, NY. Dr. Young received his bachelor’s degrees in biology and general science from Villanova University in Villanova, PA, and his doctorate in microbiology and immunology from Baylor College of Medicine in Houston, TX.
Franklin H. Top, Jr., M.D.
Senior vice president, MedImmune Ventures, Inc.
Dr. Top identifies companies that may be suitable for partnership and investment opportunities. He also serves as medical counsel to the clinical development group at MedImmune, Inc. Dr. Top is currently a board member of VaxInnate, Inc., Applied Genetic Technologies Corporation, GlycoMimetics, Inc. and Avidia, Inc. Dr. Top joined MedImmune in June 1988 as executive vice president and was elected to the board of directors where he served from 1988 to 2003. He became the company’s medical director in 1990, and held that position until he was appointed senior vice president of MedImmune Ventures in July 2004. Prior to joining MedImmune, Dr. Top served as senior vice president for clinical and regulatory affairs at Praxis Biologics from 1987 to 1988. Prior to 1987, Dr. Top served for 22 years in the U.S. Army Medical Research and Development Command, where he was appointed director, Walter Reed Army Institute of Research, in 1983. Dr. Top holds a doctorate of medicine cum laude and a bachelor of science degree in biochemistry from Yale University.
Cyrus S. Poonawalla, Ph.D.
Chairman, Serum Institute of India Ltd.
Dr. Poonawalla is chairman of the Serum Institute of India Ltd. (SIIL) and president of the Serum Institute of India Research Foundation, both based in Pune, India. His vital contribution for the past 35 years is developing SIIL as one of the world’s largest manufacturers of the measles, mumps, rubella (MMR) and diphtheria, pertussis and tetanus (DPT) vaccine groups. SIIL’s vaccines are now being used in more than 130 countries where they protect more than 50% of the world’s newborn children. His guiding principal is "No Compromise with Quality" and he maintains a commitment to "health for all with affordable vaccines." He received a Ph.D. from the University of Pune in 1988. With a highly competent team of scientists, he developed SIIL as a world-class vaccine manufacturing facility, obtaining accreditation from the World Health Organization currently for nine vaccines. Dr. Poonawalla is member of the Vaccine Production Board of the Indian Ministry of Health, and patron of the Indian Academy of Vaccinology & Immunobiology. His many awards include the 1991 Man of the Year-Shiromani Award by the Shiromani Institute in New Delhi, a 1997 Lifetime Achievement Award and 2002-03 Hall of Fame Award from the Turf Authorities of India, and the 2004 BioSpectrum Person of the Year Award. Dr. Poonawalla supports many institutions and individuals in India and abroad through personal donations and charities.
Larry King
Host, Larry King Live
Celebrating his 48th year in broadcasting in 2005, CNN's Larry King is the host of the network's Larry King Live, the network's highest-rated program. King has accumulated more than 40,000 interviews, including every U.S. president since the Ford administration. For more than four decades, King has consistently made headlines night after night with high-profile guests from Marlon Brando to Al Pacino, Eleanor Roosevelt to Nancy Reagan, Pete Rose to Michael Jordan, and such American icons as Bobby Kennedy, Dr. Martin Luther King, and Malcolm X. King has been inducted into five of the nation's leading broadcasting halls of fame and also has won a News and Documentary Emmy Award for Outstanding Interview/Interviewer. In addition to his broadcast credits, King founded the Larry King Cardiac Foundation, which has raised millions of dollars and provided life-saving cardiac procedures for nearly 60 needy children and adults. King also recently established a $1 million journalism scholarship at George Washington University's School of Media and Affairs for students from disadvantaged backgrounds. King is married to singer/actress Shawn Southwick-King and is the father of Andy, Larry Jr., Chaia, Chance and Cannon.
2005 Global Corporate Philanthropy Award
Serum Institute of India
The Serum Institute of India was founded in 1966 and has become a shining star on the global map of vaccine manufacturers. The company exports to more than 130 countries worldwide and 50 percent of children immunized in 2004 against measles and diphtheria, tetanus, and pertussis were vaccinated with Serum Institute vaccines. The company operates a state-of-the-art facility in Pune and employs world-class Good Manufacturing Practices. The Institute is recognized worldwide as a reliable source of quality vaccines for global vaccination programs. Timely supplies of quality vaccines under a dedicated cold chain have enabled the company to gain the confidence of international organizations such as the World Health Organization, UNICEF, and the Pan American Health Organization, in reaching out to countries in the most remote regions of the globe. The Serum Institute of India’s millennium endeavor is to produce from India, a developing country, vaccines that will protect at least 75 percent of the child population of planet Earth. The true extent of Serum Institute’s “Philosophy of Care” can be gauged from the uncompromising levels of safety and efficacy it has maintained in all its products. From the outset, the focus was on the assurance of unquestionable quality.
2005 Award for Scientific Excellence
Suresh Jadhav, Ph.D.
Executive Director (Q.A.) Serum Institute of India Ltd.
Dr. Suresh S. Jadhav, Executive Director (Q.A.), Serum Institute of India Ltd. Dr. Jadhav has served since 1992 as Executive Director of Serum Institute of India Ltd., Pune, which he joined as a manager, quality control (QC) in 1979. He has been instrumental in the development and adoption of the latest QC techniques and in elevating the Institute to standards on par with Western manufacturing facilities. He played a vital role in securing accreditation from World Health Organization (WHO) for Serum Institute, helping to put the Serum Institute on the global map as a supplier to U.N. agencies. Dr. Jadhav’s 34 years of technical expertise covers areas including biologicals quality control and assurance and good manufacturing practice techniques, pharmacology, standardization of biochemical methods, inspections of laboratories, and pharmacological and toxicological screening of various drugs, toxins and venoms. His expertise in the field of biologicals has been recognized in requests since 1988 as a WHO advisor on vaccine policy, newer vaccines, vaccine testing, and international standard. He has also been appointed by WHO’s Global Programme for Vaccines and Immunization as a member of their Expert Review Committee on Animal Husbandry. He served on the Sabin Vaccine Institute Task Force on Harmonization for Vaccine Supply, 2003. Dr. Jadhav holds a MPharm from Nagpur University and a Ph.D. from the Haffkine Institute, Mumbai.
2004 Global Corporate Philanthropy Award
Chiron Corporation and Howard Pien
Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide. The company’s consistent success comes from its disciplined business approach, pioneering science and skill in delivering innovations in biotechnology. Chiron believes that science has the power to improve people’s lives and harnesses that power to transform public health.
Chiron Vaccines, the world’s fifth-largest vaccines business, is headquartered in Oxford, United Kingdom, and has facilities located throughout Europe, the United States and Asia. Chiron Vaccines is the world’s second-largest manufacturer of flu vaccines and has important meningitis, pediatric and travel vaccine franchises. It is the leading vaccine manufacturer in the United Kingdom, Germany and Italy. The company’s portfolio of products includes vaccines for influenza, meningitis C, yellow fever, rabies, tick-borne encephalitis, haemophilus influenzae B (Hib), polio, mumps, measles and rubella (MMR) and diphtheria, tetanus and pertussis (whooping cough).
Howard Pien joined Chiron Corporation as president and chief executive officer in April 2003, and Chiron’s board of directors has designated him to be appointed chairman in May 2004. During Mr. Pien’s tenure at Chiron, the company acquired PowderJect Pharmaceuticals, making Chiron the second-largest manufacturer of flu vaccines worldwide. Mr. Pien has also overseen numerous initiatives to expand Chiron’s businesses, including establishment of a vaccines commercial operation in the United States and collaborative agreements to broaden the company’s research and development programs. Chiron recorded revenues of $1.8 billion in 2003.
Mr. Pien came to Chiron from GlaxoSmithKline (GSK), where he served more than three years as president, Pharmaceuticals International. In this role, he had overall responsibility for the commercial operations of the company’s international pharmaceuticals business, which encompassed 130 markets in 23 time zones, including Japan and Canada. Mr. Pien was a member of GSK’s management committee and served as a spokesman for GSK to multinational organizations such as WHO and UNAIDS on access-to-medication issues, with a particular focus on HIV/AIDS.
Before the merger of Glaxo Wellcome and SmithKline Beecham to form GSK, Mr. Pien was president of SmithKline Beecham Pharmaceuticals, with responsibility for the company’s businesses in North America and Europe as well as the vaccines business worldwide. Mr. Pien also represented SmithKline Beecham as a board member of the industry association, the Pharmaceutical Research and Manufacturers of America. Mr. Pien joined SmithKline Beecham in 1991 as vice president of new product development and was appointed to successively key positions, including senior vice president of U.S. marketing, managing director of the United Kingdom, area director of North Asia and president of U.S. Pharmaceuticals. Mr. Pien also worked for six years at Abbott Laboratories and for five years at Merck, with assignments in sales, market research, licensing and product management.
2004 Humanitarian Award
James Dewey Watson, Ph.D.
Chancellor, Cold Spring Harbor Laboratory
James D. Watson, Ph.D., who will receive the Sabin Humanitarian Award, is renowned for co-discovery of the structure of DNA (deoxyribonucleic acid), for which he shared the 1962 Nobel Prize in Physiology and Medicine with Francis Crick and Maurice Wilkins. The double helix is an elegant concept central to the emerging field of molecular biology: understanding the structure of a molecule provides clues about how it functions. In 1968, Dr. Watson became Director of Cold Spring Harbor Laboratory in New York, where he recently was appointed Chancellor.
Dr. Watson has been recognized with numerous awards, including the John J. Carry Gold Medal of the National Academy of Sciences in 1971, the Presidential Medal of Freedom in 1977, the National Medal of Science in December 1997, the Philadelphia Liberty Medal on July 4, 2000, and the Benjamin Franklin Medal awarded by the American Philosophical Society. Queen Elizabeth II proclaimed him an honorary Knight of the British Empire on January 1, 2002.
Dr. Watson is a member of the American Academy of Arts and Sciences, the American Society of Biological Chemists, the National Academy of Sciences, the American Association for Cancer Research, and the American Philosophical Society. He holds honorary affiliations with the Danish Academy of Arts and Sciences, Clare College (Cambridge University), Athenaeum (London), the Royal Society (London), and the Russian Academy of Sciences, and he has received honorary degrees from 14 universities. Apart from his many scientific papers, he is the author of books including The Double Helix; The DNA Story; Molecular Biology of the Gene; Molecular Biology of the Cell; Recombinant DNA: A Short Course; DNA: The Secret of Life; A Passion for DNA; and his 2003 memoir, Genes, Girls and Gamow.
2003 Lifetime Achievement Award
Bernard Poussot
Executive Vice President, Wyeth
Bernard Poussot, Executive Vice President of Wyeth (formerly American Home Products) and President of Wyeth Pharmaceuticals, joined the Company in 1986, as Deputy General Manager of Wyeth France. A year later, he was promoted to President-General Manager, Wyeth France, a position he held until 1991, when he was named head of Wyeth Europe and relocated to St. Davids, Pennsylvania. Two years later, his responsibilities were extended to Asia, Latin America and International Marketing, when he was named Executive Vice President of Wyeth-Ayerst International. In 1996, he was named President of Wyeth-Ayerst International. In 1997, Mr. Poussot became President, Wyeth-Ayerst Pharmaceuticals, the worldwide pharmaceutical division of the Corporation. He has been a member of the Corporate Operations Committee since 1997 and in 2001 was elected Senior Vice President of the Corporation. In 2002, he was elected to Executive Vice President of Wyeth when R&D was added to his responsibilities.
Prior to joining Wyeth, Mr. Poussot was Director of Marketing Worldwide for Searle in Chicago from 1984-1986 after being Director of Marketing and Sales for Searle France from 1981-1984. He began his career with Laboratoires Merck Sharp & Dohme in Paris in 1975 serving in various marketing positions from 1977-1980, until he became Director of a Pharmaceutical Division in 1980.
He graduated from Ecole Supérieure de Commerce de Paris in 1975 and fulfilled his civil servant obligation as Secretary General to the Governor of Casablanca-Morocco in charge of Economic Affairs.
Mr. Poussot serves on the Boards of the World Affairs Council, the University of Pennsylvania School of Dental Medicine, the Eisenhower Fellowships, the Opera Company of Philadelphia and the French American Chamber of Commerce. He lives in Villanova, Pennsylvania with his wife, Delphine, and their three children.
2003 Humanitarian Award
Irwin Redlener, M.D.
President, The Children’s Health Fund
Irwin Redlener, M.D. is President and co-founder of The Children’s Health Fund, a philanthropic initiative created to develop and support health care programs for medically underserved children. At Montefiore Medical Center he is President of the Children’s Hospital and Director of Community Pediatrics. He is also Professor of Pediatrics at the Albert Einstein College of Medicine and Lecturer in Pediatrics at Harvard Medical School.
The New York Children’s Health Project, the country’s largest health care program for homeless children, was developed in 1987 by Dr. Redlener. It is the model for a number of innovative health care projects in The Children’s Health Fund’s program network for disadvantaged child populations in 15 urban and rural communities across the country.
Dr. Redlener helped organize and continues to serve on the Task Force on Terrorism of the American Academy of Pediatrics and the pediatric disaster committee of the National Association of Children’s Hospitals. He has also been co-chairman of the Healthy Start Advisory Group for America’s Promise: The Alliance for Youth and served a two year term as Chairman of the National Advisory Council on the National Health Service Corps. He leads Kids First, Kids Now!, a national initiative proposing access to comprehensive health care for all children. From 1986 to 1987 he was Director of Grants and Medical Director of USA for Africa and Hands Across America. Dr. Redlener practiced general pediatrics and directed a special care nursery for seven years. Previous experience also includes development and direction of a pediatric intensive care unit as a member of the faculty of the University of Miami School of Medicine. He founded and directed a regional program in Florida for the management and prevention of child abuse and neglect.
Dr. Redlener and his wife Karen, Director of the New York Children’s Health Project, have grown children and a grandson.
Paul Simon
Musician and Co-Founder, The Children’s Health Fund
It is rare that an artist who captures and expresses the sentiments of a particular era goes on to expand his horizons while remaining a powerful cultural and personal force. Paul Simon is undoubtedly among this select group. Performing with Art Garfunkel, a childhood friend, as "Simon and Garfunkel", he was largely responsible for writing, arranging, and recording the duo’s classic folk and rock songs.
Last year, Mr. Simon was a recipient of the prestigious Kennedy Center Award. Most recently, Mr. Simon wrote the song "Father and Daughter" for the animated movie "The Wild Thornberrys", which was nominated for an Academy Award for Best Song.
Mr. Simon’s contributions to charitable causes attest to his commitment to civic involvement. He is cofounder of the Children’s Health Fund, bringing medical care to homeless and indigent children. He has raised money for the Nature Conservancy, the Fund for Detained and Imprisoned Children in South Africa, and AmFar. In 1989, the United Negro College Fund bestowed upon him its highest honor, the Frederick D. Patterson Award.
Stephen Joel Trachtenberg, J.D., M.P.A., M.D. (hon.)
President, The George Washington University
Stephen Joel Trachtenberg, J.D., M.P.A., M.D. (hon.) is the 15th president of The George Washington University since its founding in 1821. At The George Washington University since 1988, Trachtenberg was previously president and professor of public administration for 11 years at the University of Hartford. Prior to that, he was Dean of Arts and Sciences and Vice President at Boston University for eight years.
During the Johnson Administration, Trachtenberg was special assistant to the U.S. Education Commissioner, Department of Health, Education and Welfare. Preceding his academic career, he was an attorney for the U.S. Atomic Energy Commission and an aide to a U.S. Congressman. Trachtenberg’s books and articles in academic and lay journals have received wide acclaim. Recognition for his contributions to education includes numerous awards and honorary degrees. Last year he was elected a Fellow in the nation’s preeminent learned society, The American Academy of Arts & Sciences.
For the past three years, Trachtenberg has chaired the Rhodes Scholarship Selection Committee for Maryland and the District of Columbia. In 2002 he received the U.S. Department of the Treasury’s Medal of Merit. In 2000 King Mohammed VI of Morocco decorated him as a "Grand Officier Du Wissam Al Alaoui." In 1997 the U.S. State Department gave him its Distinguished Public Service Award. In 1995 Columbia University honored him with their John Jay Award for Outstanding Professional Achievement.
Trachtenberg is president-elect of the District of Columbia Chamber of Commerce and also serves on the boards of the Greater Washington Board of Trade, the Urban League of Greater Washington, the D.C. Federal City Council, and Riggs Bank. He has been appointed by the city’s Mayor to serve on the District of Columbia Tax Revision Commission, as well as the District of Columbia Committee to Promote Washington. He serves on the boards of the Chief of Naval Operations (CNO) Executive Panel and the International Association of University Presidents. He is a member of the Council on Foreign Relations. In 1988, he was elected to the National Collegiate Athletic Association (NCAA) Presidents Commission.
2002 Lifetime Achievement Award
Richard C. Holbrooke
Richard C. Holbrooke served as the U.S. Ambassador to the United Nations, where he was also a member of President Clinton's cabinet, from 1999 to 2001 He played a central role in the development of U.S. policy toward the United Nations, the Balkans, Africa, Asia, the Middle East and humanitarian crisis issues such as AIDS.
As Assistant Secretary of State for Europe from 1994 to 1996, Holbrooke was chief architect of the momentous 1995 Dayton peace agreement that ended the war in Bosnia. From 1993 to 1994 he was U.S. Ambassador to Germany. From 1977 to 1981 he was Assistant Secretary of State for East Asian and Pacific Affairs and was in charge of U.S. relations with China when Sino-American relations were normalized in 1978. He was also Peace Corps Director in Morocco (1970-72), Managing Editor of Foreign Policy (1972-76), and held senior positions at two Wall Street firms.
Holbrooke has written two books: To End a War, a memoir of the Dayton negotiations, and, as co-author, Counsel to the President, Clark Clifford's memoir, as well as a volume of The Pentagon Papers. He is Founding Chairman of The American Academy in Berlin, a center for U.S.-German cultural exchange, and President and CEO of the Global Business Council, the business alliance against HIV/AIDS. He is currently Vice Chairman of Perseus, a leading private equity firm.
2002 Humanitarian Award
Jean-Pierre Garnier, Ph.D.
Dr. Garnier is the Chief Executive Officer of GlaxoSmithKline. He assumed this role in December 2000 with the merger of SmithKline Beecham and Glaxo Wellcome.
Dr. Garnier joined SmithKline Beecham in 1990 as President of its pharmaceutical business in North America and served as Chairman, Pharmaceuticals from 1994 until his appointment as Chief Operating Officer in 1995. He was elected to the company's Board of Directors in 1992. He became Chief Executive Officer-elect in December 1999. He became Chief Executive Officer in April 2000. Prior to SmithKline Beecham, Dr. Garnier served as President of Schering-Plough's US business.
Dr. Garnier serves on the Boards of Directors of the United Technologies Corporation and the Eisenhower Exchange Fellowships, Inc. In January 1997, Dr. Garnier was selected by President Chirac of France to receive the Chevalier de la Légion d'Honneur. In 2001, he was named one of 50 "Stars of Europe" by BusinessWeek magazine. Dr. Garnier holds a Ph.D. in pharmacology and an MS in pharmaceutical science from the University of Louis Pasteur in France. As a Fulbright Scholar, he earned an MBA at Stanford University, California, in 1974.
2001 Lifetime Achievement Award
John W. Rowe, M.D.
Dr. Rowe is President and CEO of Aetna US Healthcare, the nation's largest healthcare insurer. Prior to joining Aetna, Dr. Rowe served as President and Chief Executive Officer of Mount Sinai NYU Health. With an annual budget of $1.8 billion, a staff of 4,000 physicians and total employees of approximately 14,000, Mount Sinai NYU Health is one of the nation's largest health care organizations. Prior to the Mount Sinai NYU Health merger, Dr. Rowe was President of The Mount Sinai Hospital and the Mount Sinai School of Medicine in New York City. He serves as a Professor of Medicine and Geriatrics at the Mount Sinai School of Medicine.
Before joining Mount Sinai in 1988, Dr. Rowe was a Professor of Medicine and the founding Director of the Division on Aging at the Harvard Medical School and Chief of Gerontology at Boston's Beth Israel Hospital. He has authored over 200 scientific publications, mostly in physiology of the aging process, and a leading textbook of geriatric medicine. Dr. Rowe has received many honors and awards for his research and health policy efforts regarding care of the elderly. Dr. Rowe was Director of the MacArthur Foundation Research Network on Successful Aging and is co-author, with Robert Kahn, Ph.D., of Successful Aging (Pantheon, 1998). He served on the Board of Governors of the American Board of Internal Medicine and as President of the Gerontological Society of America, and is a member of the Institute of Medicine of the National Academy of Science and the Medicare Payment Advisory Commission.
2001 Humanitarian Award
Jean-Jacques Bertrand
Jean-Jacques Bertrand is Chairman and CEO of Aventis Pasteur, formerly Pasteur Mérieux Connaught. He has held this position since 1994. On December 15, 1999, he was also appointed Deputy to the CEO of Aventis Pharma.
Jean-Jacques Bertrand graduated from HEC in 1963 (HEC: Hautes Études Commerciales). He was Marketing Director of Theraplix (Rhône-Poulenc Group) and Rhône Poulenc International Health, before becoming Chairman of Theraplix in 1981 and of Specia (Rhône-Poulenc Group) in 1984.
In 1985, Jean-Jacques Bertrand was appointed COO of Rhône-Poulenc Pharmaceutical Operations for France, then, in 1987, for the whole world. In 1990, Jean-Jacques Bertrand was appointed COO of Rhône-Poulenc Rorer.
Jean-Jacques Bertrand is a Board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and is representing the contributing global vaccine producers and the Board of the Global Alliance for Vaccines and Immunization (GAVI).
He is also, since January 11, 2000, Chairman of the Syndicat National de l'Industrie Pharmaceutique (SNIP).
2000 Lifetime Achievement Award
Raymond V. Gilmartin
View Acceptance Speech
Raymond V. Gilmartin joined Merck & Co. Inc. in 1994 as President and Chief Executive Officer. He was named to the additional post of Chairman of the Board in November 1994. Prior to joining Merck, Mr. Gilmartin was Chairman, President and Chief Executive Officer of Becton Dickinson and Company. He worked at Becton Dickinson for 18 years, joining the company in 1876 as Vice President, Strategic Planning, then took on a number of positions of increasing responsibility over the years.
An active participant in health industry affairs, Mr. Gilmartin is Chairman of the Pharmaceutical Research & Manufacturers of America. He also serves as Chairman of the Healthcare Leadership Council, a group dedicated to excellence in America's health care system; and he is Chairman of Valley Health System, Inc., the parent company of two community-based hospitals in northern New Jersey.
Mr. Gilmartin serves as Chairman of the Board of Associates of the Harvard Business School. He is Director of The College Fund/UNCF, and the Ethics Resource Center. He is a member of the Business Roundtable, the Business Council and the Council on Competitiveness. He is a Trustee of the Conference Board and the Committee for Economic Development. He also serves on the Board of Directors of General Mills, Inc. and Public Service Enterprise Group, Inc. Mr. Gilmartin graduated from union College in 1963 with a BS in Electrical Engineering. He received an MBA from Harvard Business School in 1968.
2000 Humanitarian Award
Mary Carol Flake de Flores
Mary Carol Flake de Flores was born in Memphis, Tennessee and is the eldest of seven children. Raised in Cincinnati, Ohio, Mary attended college at Louisiana State University where she majored in Textiles and Merchandising, where she met her husband, Carlos Roberto Flores.
Ms. de Flores has been committed to her family and home, as well as working as a volunteer for various activities in support of the Honduran community. She has worked tirelessly for many causes including: Founder and Honorary President of Fundacion Hondura para el Niño con Cáncer (Honduran Foundation for Children with Cancer), Honorary President of Pro-Ayuda del Hospital San Felipe (Committee in Support of the San Felipe Hospital) which promotes the improvement of service to malnourished children, Honorary President of the 1999 Special Olympics and many more.
She has received numerous honors from the national and international community including a Medal of Merit from the Honduran Federation of Women Fellowship for outstanding work during and after Hurricane Mitch in October 1998 when she assumed leadership of the emergency relief efforts, meeting with heads of state of many nations, leaders of many relief organizations, businesses, religious institutions and medical teams to help raise funds and build support for the relief effort. The International Commission of Women nominated her for the 1997 International Woman of the Year. She received a Star of Caribbean Award from Caribbean Latin American Action in 1999. Mary Flores served as Keynote speaker for the National Congress for Women in Mexico City in 1999.
1998 Lifetime Achievement Award
Vernon R. Loucks Jr.
Vernon R. Loucks Jr. is Chairman and Chief Executive Officer of Baxter International Inc., having served in the latter capacity since May 1980.
Prior to joining Baxter, Mr. Loucks was a Senior Management Consultant for George Fry and Associates. He joined Baxter in 1966 as Assistant to the President and Chief Executive Officer. His career at Baxter has included senior positions in both domestic and international operations. In December 1975, he was elected to the company's board of directors. He became President and Chief Operating Officer in 1976, Chief Executive Officer in 1980 and was named Chairman in 1987.
Mr. Loucks is active in business, education and civic affairs. He is director of Affymetrix, Inc., Anheuser-Busch Companies, Inc., Coastcast Corp., The Dun & Bradstreet Corporation, Emerson Electric Co., and The Quaker Oats Company. He is a member of The Business Council, the Healthcare Leadership Council and the Health, Welfare and Retirement Income Task Force of the Business Roundtable. Mr. Loucks is a trustee of Rush-Presbyterian/St. Luke's Medical Center in Chicago, and has served as Director of the Harvard Business School Board of Directors of the Associates and as Senior Fellow of the Yale Corporation. Mr. Loucks also is a member of the board of the International Institute for Management Development Foundation, and of the advisory board of Nestlé USA. Mr. Loucks also is a member of the Singapore-US Business Council. He is former (1983) Chairman of the Health Industry Manufacturers Association and served as special adviser to the Director of the U.S. National Institutes of Health from January 1983 to September 1986.
In 1982, Mr. Loucks received two honors: Financial World magazine selected him as one of the "Outstanding Chief Executive Officers of 1981", and the Chicago Institute of Medicine awarded him the Citizen Fellowship Award. In 1983, Business Month named Baxter one of the "five best-managed companies" in the United States. In 1984, Financial World named Mr. Loucks 1983's most outstanding executive officer in the health-care industry. In 1986, he received the B'nai B'rith Youth Services National Health Care Award. He was elected to the Chicago Business Hall of Fame, sponsored by Junior Achievement, in 1987. In 1989, Mr. Loucks received the William McCormick Blair award from Yale University and the Marine Corps' Semper Fidelis Award. He received the Distinguished Humanitarian Award in 1992 from the Saint Barnabas Burn Foundation, and the Alexis de Tocqueville Award for lifetime community service from the United Way of Lake County in 1993. In 1996, he received the "Industrialist of the Year Award" from the American Israel Chamber of Commerce, and in 1997 he was awarded the Yale Medal from Yale University.
Mr. Loucks holds a bachelor's degree in history from Yale University and a master's degree from the Harvard Graduate School of Business Administration. He is a veteran of the U.S. Marine Corps, serving as first lieutenant.
1998 Humanitarian Award
Nicholas Zwick
Nicholas Zwick has been an active member of the Young President's Organization since 1994 holding Board positions of Secretary/Chapter Parliamentarian and currently Forum Chairman of the New Jersey Chapter.
Nick is a co-founder of Dialogic Corporation, the leading manufacturer of high performance, standards-based computer technology (CT) components. Computer Telephony exists whenever computers and telephone telephony work together to automate or enhance the productivity of a telephone call. Traditional examples of CT are voice mail and telephone banking. Current and emerging applications are voice command dialing of your mobile phone and making telephone calls over the internet. Nick is Director of the Company since its inception in 1983, became president in 1985, has been the Chairman of the Board since March 1993, and took the company public in 1994. He holds a Bachelor of Engineering degree from the State University of New York at Stony Brook.
1996 Humanitarian Award
Kathryn G. Thompson
Receiving her bachelor’s degree in business administration from Southern Methodist University, Kathryn G. Thompson first came to California in 1967. During the past twenty-nine years she has started numerous companies including the Kathryn G. Thompson Company. Her activities and involvement as a builder and developer include the design and building of both residential and commercial properties. Overall, she has built more than 15,000 apartments, homes and condominiums.
Ms. Thompson has also devoted a great deal of her time to sharing her knowledge of the real estate industry. She has participated in programs and presentations for the Urban Land Institute, Stanford University Graduate School of Business, the Pacific Coast Builders Conference, the California Real Estate Association, IUS School of Urban and Regional Planning, the NYU Pension Fund Investment in Real Estate Conference, and the UCI Graduate School of Management.
As a philanthropist, community leader and lecturer, Ms. Thompson serves on the boards of numerous charitable organizations, including the Boy Scouts of America, the United Way, the Orangewood Children’s Foundation and the Orange County Performing Arts Center. She is a trustee of the Children’s Hospital Foundation and the University of California Irvine, College of Medicine.
She has been the recipient of numerous honors and awards. In 1995, she was appointed by President Clinton to the Board of Directors of the Federal Mortgage Association (Fannie Mae) and also received the Orange County Business Journal’s "1995 Women in Business Award". She has been chosen as one of the 74 "Women Who are Changing American Politics" by Campaign and Elections magazine, and was inducted into the California Building Industry Foundation’s Hall of Fame in 1993.
